People with Mitochondrial Disease Have Significant Medical Costs Infographic / July 30, 2019July 26, 2022
Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide for the Treatment of Dry Age-Related Macular Degeneration with Geographic Atrophy Press Release / December 10, 2018July 26, 2022
Stealth BioTherapeutics Expands Pipeline, Advances New Compound Press Release / August 14, 2018June 30, 2022
Stealth BioTherapeutics Announces $100m Financings to Advance Clinical Development of Elamipretide and Pipeline Press Release / June 18, 2018July 26, 2022
The Journey to Diagnosis for People with Mitochondrial Disease Infographic / June 11, 2018August 27, 2019
Stealth BioTherapeutics Granted Orphan Drug Designation of Elamipretide for Treatment of Leber’s Hereditary Optic Neuropathy Press Release / April 30, 2018July 26, 2022
Stealth BioTherapeutics Granted Orphan Drug Designation for Elamipretide for Treatment of Barth Syndrome Press Release / April 9, 2018July 26, 2022
Stealth BioTherapeutics Completes Enrollment of Study for the Treatment of Barth Syndrome Press Release / March 6, 2018July 26, 2022
